Search Results
Onco
Daily
Facebook
RSS
X
Youtube
Linkedin
October, 2024
October 2024
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
« Sep
MD Anderson Cancer Center
Feb 26, 2024, 19:07 |
Blog
Naveen Pemmaraju: Our brand new paper just out in L and L
Naveen Pemmaraju posted on X/Twitter: “Delighted to share our brand new paper just out in…
Feb 26, 2024, 00:02 |
Blog
Ishwaria Subbiah: My 1st time in The White House!
Ishwaria Subbiah shared on LinkedIn: “My 1st time in The White House! Action-centered discussions with…
Feb 25, 2024, 15:34 |
Blog
Ishwaria Subbiah: Teaching (and learning from) oncologists and palliative care physician practicing across Indonesia
Ishwaria Subbiah shared on X: "Friday night in Jakarta! Equity in Action! Teaching (and learning…
Feb 23, 2024, 18:03 |
Blog
Vivek Subbiah: The development of armored CAR T-cells may enable CAR T to be efficacious against a broader range of malignancies
Vivek Subbiah recently shared on LinkedIn: "'CARs are sharpening their weapons'. The development of armored…
Feb 22, 2024, 23:12 |
Blog
Vivek Subbiah: A look at breakthrough treatment for sickle cell anemia
Vivek Subbiah shared on X: “Jimi and Victoria met in person for the first time…
Feb 22, 2024, 18:29 |
Blog
Jared K. Burks: I am incredibly proud of the team at FCCIF-NC
Jared K. Burks, Professor and Co-Director of the Flow Cytometry and Cellular Imaging Core Facility…
Feb 20, 2024, 18:51 |
Blog
Vivek Subbiah: Our editorial comments on the ASCO TAPUR study spearheaded by the amazing Richard Schilsky
Vivek Subbiah recently shared on X/Twitter: "Hot off the press Pleased to share our editorial…
Feb 19, 2024, 18:18 |
Blog
Anas Younes: We are developing more than one drug for the same disease indication, so we can build future combination regimens
Anas Younes posted on LinkedIn: ''Our hematology team spent the last 3 days reviewing our…
Feb 19, 2024, 17:17 |
Career
Stacie Lindsey: We are thrilled that the ESMO announced that the 2024 TAT Honorary Award is bestowed to Dr. Funda Meric-Bernstam
Stacie Lindsey, CEO of Cholangiocarcinoma Foundation, shared on LinkedIn: "We are thrilled that the ESMO…
Feb 18, 2024, 15:51 |
Blog
Hagop Kantarjian: In this Ph1b trial, single agent SQ blinatumomab resulted in a high MRD-negative complete remission rate
Hagop Kantarjian, Chair of the Department of Leukemia at The University of Texas MD Anderson Cancer…
121
122
123
124
125
All:
1454
Posts:
1221 - 1230
ASTRO24: 20 Posts Not To Miss From Day 1
Fran Drescher and Uterine Cancer: How She Went Against, How She Survived, and More
Top 100 Xfluencers in Pediatric Hematology/Oncology: Key Opinion Leaders to follow on X (Twitter) in 2024
Jeff Bridges and Lymphoma: How He Went Against, How He Survived, and More
100 Influential Women in Oncology: Key Opinion Leaders to Follow on Social Media in 2024: Part 5
Special Coverage
ASCO Annual Meeting
May 30 - June 4, 2024
Yvonne Award 2024
May 31, 2024
OncoThon 2024, Online
Feb. 15, 2024
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Facebook
RSS Feed
X
Linkedin
Youtube